Alexander Drilon MD (@alexdrilon) 's Twitter Profile
Alexander Drilon MD

@alexdrilon

Chief, Early Drug Development Service; Associate Attending Physician, Thoracic Oncology Service; Memorial Sloan Kettering Cancer Center

ID: 389758857

linkhttps://www.mskcc.org/cancer-care/doctors/alexander-drilon calendar_today12-10-2011 23:21:19

171 Tweet

4,4K Takipçi

215 Takip Edilen

Alexander Drilon MD (@alexdrilon) 's Twitter Profile Photo
Alexander Drilon MD
@alexdrilon

4 years ago

The first publication of larotrectinib in NTRK fusion+ lung cancers alone is out. Beyond the initial systemic & intracranial response gains, the ~35 month median PFS and the ~41 month median OS impress. Wonderful news for patients, advocates, and providers across the world.